|
|
|
|
| LEADER |
00000cam a2200000Mi 4500 |
| 001 |
SCIDIR_ocn871781260 |
| 003 |
OCoLC |
| 005 |
20231120111531.0 |
| 006 |
m o d |
| 007 |
cr |n|---||||| |
| 008 |
140306s1984 vtu o 000 0 eng d |
| 040 |
|
|
|a MHW
|b eng
|e pn
|c MHW
|d EBLCP
|d IDEBK
|d E7B
|d OPELS
|d N$T
|d OCLCF
|d OCLCQ
|d DEBSZ
|d OCLCQ
|d MERUC
|d OCLCQ
|d VLY
|d OCLCO
|d OCLCQ
|
| 020 |
|
|
|a 9781483278131
|q (electronic bk.)
|
| 020 |
|
|
|a 1483278131
|q (electronic bk.)
|
| 020 |
|
|
|z 9780444903778
|
| 035 |
|
|
|a (OCoLC)871781260
|
| 050 |
|
4 |
|a QP356.4
|b .N4773 1984
|
| 072 |
|
7 |
|a MED
|x 075000
|2 bisacsh
|
| 072 |
|
7 |
|a SCI
|x 036000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 612.814
|a 612/.814
|
| 245 |
0 |
0 |
|a Neuroendocrine Perspectives.
|n Volume 3 /
|c edited by Eugenio E. M�uller and Robert M. MacLeod.
|
| 260 |
|
|
|a Burlington :
|b Elsevier Science,
|c 1984.
|
| 300 |
|
|
|a 1 online resource (399 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 500 |
|
|
|a Neuroendocrine Perspectives.
|
| 505 |
0 |
|
|a Front Cover; Neuroendocrine Perspectives; Copyright Page; Introduction; Contributors; Table of Contents; Chapter 1. Topography of chemically identified neurons in the central nervous system: progress in 1981 -1983; INTRODUCTION; AMINO ACIDS; ACETYLCHOLINE; BIOGENIC AMINES; NEUROPEPTIDES; CONCLUSIONS; ACKNOWLEDGMENTS; REFERENCES; Chapter 2. Hypothalamic organization of corticotropin releasing factor (CRF) producing structures; INTRODUCTION; THE HYPOPHYSIOTROPIC NEURONS; LOCATION OF HYPOTHALAMIC CRF-PRODUCING STRUCTURES; THE ROLE OF THE HYPOTHALAMIC PARAVENTRICULAR NUCLEUS
|
| 505 |
8 |
|
|a IS THE NEURAL LOBE INVOLVED IN THE CONTROL OF ACTH SECRETION?WHAT IS CRF?; THE 41-RESIDUE CRF (CRF-41); THE NEUROHYPOPHYSEAL PEPTIDES VASOPRESSIN AND OXYTOCIN; ANGIOTENSIN II; EPINEPHRINE AND NOREPINEPHRINE; OTHER SUBSTANCES WITH CRF ACTIVITY; PERSPECTIVES OF CRF; REFERENCES; Chapter 3. Neuropeptides in the cerebrospinal fluid; INTRODUCTION; HYPOPHYSIOTROPIC FUNCTION; MECHANISMS BY WHICH NEURAL PEPTIDES MIGHT REACH THE CSF; BIOLOGIC ACTION; ENDOGENOUS NEURAL PEPTIDES IN THE CSF; SUMMARY AND CONCLUSIONS; REFERENCES
|
| 505 |
8 |
|
|a Chapter 4. Neuropeptides in shock and traumatic injury: sites and mechanisms of actionINTRODUCTION; MULTIPLE FORMS OF ENDOGENOUS OPIOIDS AND THEIR LOCALIZATIONS; REGULATION OF ENDOGENOUS OPIOID RELEASE; MULTIPLE OPIOID RECEPTORS; ENDOGENOUS OPIOID SYSTEMS IN THE PATHOPHYSIOLOGY OF SHOCK; NEUROENDOCRINE-ENDOGENOUS OPIOID RELATIONSHIPS IN EXPERIMENTAL SHOCK; THYROTROPIN RELEASING HORMONE AS A PHYSIOLOGICAL ANTAGONIST OF OPIOID SYSTEMS; CONCLUSIONS AND PERSPECTIVES; ACKNOWLEDGMENTS; REFERENCES; Chapter 5. Ectopic hormone production by tumors: growth hormone-releasing factor
|
| 505 |
8 |
|
|a INTRODUCTION AND HISTORICAL BACKGROUNDCLINICAL STUDIES SUGGESTING ECTOPIC PRODUCTION OF GRF; BIOLOGIC CHARACTERIZATION OF ECTOPIC GH-RELEASING FACTOR; ISOLATION AND CHARACTERIZATION OF ECTOPIC GRF; CLINICAL EFFECTS OF SYNTHETIC GRF; RADIOIMMUNOASSAY OF GRF; CLINICAL IMPLICATIONS OF ENDOGENOUS GRF; POSSIBLE ROLE OF HYPOTHALAMIC GRF IN THE ETIOLOGY OF GH-SECRETING PITUITARY TUMORS; ACKNOWLEDGMENT; REFERENCES; Chapter 6. The onset of female puberty: underlying neuroendocrine mechanisms; INTRODUCTION; THE INITIATION OF GONADOTROPIN RELEASE; THE INITIATION OF OVARIAN STEROID SECRETION
|
| 505 |
8 |
|
|a THE NEONATAL-INFANTILE PERIODTHE JUVENILE PERIOD (CHILDHOOD); THE ONSET OF PUBERTY; THE FIRST PREOVULATORY SURGE OF GONADOTROPINS; ACKNOWLEDGMENTS; REFERENCES; Chapter 7. Prolactin and ovarian function; INTRODUCTION; PROLACTIN AND THE NORMAL OVARIAN CYCLE; PROLACTIN AND PUBERTY; LACTATION AND OVARIAN ACTIVITY; CONCLUSIONS; REFERENCES; Chapter 8. Antimitotic actions of dopaminergic drugs on human pituitary tumors; INTRODUCTION; EFFECTS ON THE SYNTHESIS AND SECRETION OF PROLACTIN; EFFECTS ON CELL DIVISION; DATA FROM EXPERIMENTAL RAT PITUITARY TUMOR STUDIES; STUDIES IN MAN; CONCLUSIONS
|
| 650 |
|
0 |
|a Neuroendocrinology.
|
| 650 |
|
2 |
|a Neuroendocrinology
|0 (DNLM)D009452
|
| 650 |
|
6 |
|a Neuroendocrinologie.
|0 (CaQQLa)201-0089756
|
| 650 |
|
7 |
|a MEDICAL
|x Physiology.
|2 bisacsh
|
| 650 |
|
7 |
|a SCIENCE
|x Life Sciences
|x Human Anatomy & Physiology.
|2 bisacsh
|
| 650 |
|
7 |
|a Neuroendocrinology.
|2 fast
|0 (OCoLC)fst01036341
|
| 700 |
1 |
|
|a M�uller, E. E.
|
| 700 |
1 |
|
|a MacLeod, Robert M.
|
| 776 |
0 |
8 |
|i Print version:
|z 9780444903778
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780444903778
|z Texto completo
|
